Iranian Society of Gynecology Oncology


1 Imam Hospital, Mazandaran University of Medical Sciences, Sari, Iran

2 Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran

3 Imam Khomeini Hospital Complex Hospital, Tehran University of Medical Sciences, Tehran, Iran


Introduction: One of the rare ovarian neoplasms is sclerosing stromal tumor (SST). The most common age at presentation of sclerosing stromal tumor is the second and third decades of life. Usually this tumor presents with menstrual irregularity and pelvic pain as reported previously. Surgery is mandatory for diagnosis because there is not any distinctive feature to diagnose by imaging techniques.
Case Presentation: Our case in this report is a 26-year-old woman presented with pelvic pain. We conducted routine laboratory tests and checked ovarian mass tumor markers preoperatively. Due to her normal hormonal status in physical examination, we did not request more hormonal laboratory tests. However on imaging, we did not suspect benign tumor. Doppler sonography showed low resistance flow in peripheral and center of the mass. Right ovarian mass was resected and diagnosed as ovarian stromal tumor compatible with sclerosing stromal tumor. Unexpectedly at operation, we encountered severe hemorrhage from peritoneal surface so that conservative management such as packing and suturing or cauterization was not helpful. Finally, argon coagulation stopped bleeding. All coagulation laboratory tests requested by a hematologist were normal.
Conclusions: In conclusion, we believe that vascular endothelial growth factor (VEGF) production of tumor is responsible for massive bleeding.


  1. Chalvardjian A, Scully RE. Sclerosing stromal tumors of the ovary. Cancer. 1973;31(3):664-70.<664::AID-CNCR2820310327>3.0.CO;2-F [DOI:10.1002/1097-0142(197303)31:33.0.CO;2-F]
  2. Ismail SM, Walker SM. Bilateral virilizing sclerosing stromal tumours of the ovary in a pregnant woman with Gorlin's syndrome: implications for pathogenesis of ovarian stromal neoplasms. Histopathology. 1990;17(2):159-63. [DOI:10.1111/j.1365-2559.1990.tb00688.x]
  3. Kawauchi S, Tsuji T, Kaku T, Kamura T, Nakano H, Tsuneyoshi M. Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature. Am J Surg Pathol. 1998;22(1):83-92. [DOI:10.1097/00000478-199801000-00011]
  4. Joja I, Okuno K, Tsunoda M, Takeda Y, Sugita K, Mizutani Y, et al. Sclerosing stromal tumor of the ovary: US, MR, and dynamic MR findings. J Comput Assist Tomogr. 2001;25(2):201-6. [DOI:10.1097/00004728-200103000-00007]
  5. Furukawa S, Kanno K, Kojima M, Ohara M, Soeda S, Suzuki S, et al. Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy. Int J Surg Case Rep. 2015;9:72-4. [DOI:10.1016/j.ijscr.2015.02.002]
  6. Khanna M, Khanna A, Manjari M. Sclerosing stromal tumor of ovary: A case report. Case Reports Pathol. 2012;2012:1-3. [DOI:10.1155/2012/592836]
  7. Giuseppe M. Sclerosing stromal tumor of the ovary. Edmondo Govoni. 1983;402(2):155-61. [DOI:10.1007/BF00695057]
  8. Gwin K, Marino-Enriquez A, Martel M, Reyes-Mugica M. Sclerosing stromal tumor: an important differential diagnosis of ovarian neoplasms in childhood and adolescence. Pediatr Dev Pathol. 2009;12(5):366-70. [DOI:10.2350/08-10-0545.1]
  9. Kaygusuz EI, Cesur S, Cetiner H, Yavuz H, Koc N. Sclerosing stromal tumour in young women: clinicopathologic and immunohistochemical spectrum. J Clin Diagn Res. 2013;7(9):1932-5. [DOI:10.7860/JCDR/2013/6031.3373]
  10. Ozdemir O, Sari ME, Sen E, Kurt A, Ileri AB, Atalay CR. Sclerosing stromal tumour of the ovary: A case report and the review of literature. Niger Med J. 2014;55(5):432-7. [DOI:10.4103/0300-1652.140391]